IL-1 receptor antagonist anakinra enhances tumour growth inhibition in mice receiving peptide vaccination and beta-(1-3),(1-6)-D-glucan.
Harnack
Ulf
U
Medical Clinic of Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Johnen
Heiko
H
Pecher
Gabriele
G
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000494:pharmacology*; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D004357:Drug Synergism; D005260:Female; D005936:Glucans / Q000494:pharmacology*; D051034:Inhibitor of Apoptosis Proteins; D053590:Interleukin 1 Receptor Antagonist Protein / Q000494:pharmacology*; D015850:Interleukin-6 / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D008869:Microtubule-Associated Proteins / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D000077022:Survivin; D022223:Vaccines, Subunit / Q000276:immunology / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; C107489:BIRC5 protein, human; D019496:Cancer Vaccines; D005936:Glucans; D051034:Inhibitor of Apoptosis Proteins; D053590:Interleukin 1 Receptor Antagonist Protein; D015850:Interleukin-6; D008869:Microtubule-Associated Proteins; D010446:Peptide Fragments; D017472:Receptors, Interleukin-1; D000077022:Survivin; D022223:Vaccines, Subunit; C033671:epiglucan